ArticleScientific reports2025
Transcriptional reprogramming in oral squamous cell carcinoma.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Transmembrane protein 9 as a novel biomarker promotes oral squamous cell carcinoma growth via IL1RN and serves as an immune therapeutic target.Translational cancer research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oral squamous cell carcinoma (OSCC) is a prevalent form of cancer globally. This disease is characterized by its complex genetic underpinnings, involving the intricate regulation of multiple genes. Genetic factors influence cellular processes such as growth, differentiation, and apoptosis of oral mucosal cells, thereby promoting or inhibiting tumor formation and progression. Furthermore, environmental factors-including smoking, alcohol consumption, and human papillomavirus (HPV) infection-can significantly increase the risk of developing OSCC. These external influences can impact the disease in several ways. Delayed clinical detection and the absence of specific biomarkers, coupled with expensive treatment alternatives, contribute to poor prognoses among OSCC patients. Thus, identifying OSCC biomarkers has become imperative. This study investigates publicly accessible sequencing data of oral mucosal tissues from four distinct datasets-GSE23558, GSE30784, GSE36090, and GSE51010-archived in the Gene Expression Omnibus (GEO) database. By analyzing these datasets, which encompass a range of genetic profiles and experimental conditions, the study seeks to uncover critical biomarkers and molecular pathways involved in the early stages of OSCC development. The primary objective is to identify pivotal genes linked to the onset of OSCC. The findings provide preliminary evidence for therapeutic targets in OSCC and may serve as a robust foundation for subsequent biological research endeavors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.